Clover Health Investments Corp. (NASDAQ:CLOV) went up by 1.59% from its latest closing price compared to the recent 1-year high of $3.90. The company’s stock price has collected 3.23% of gains in the last five trading sessions. The Wall Street Journal reported on 02/24/22 that Occidental Petroleum, Coinbase, fuboTV, Apple: What to Watch in the Stock Market Today
Is It Worth Investing in Clover Health Investments Corp. (NASDAQ :CLOV) Right Now?
Opinions of the stock are interesting as 1 analysts out of 6 who provided ratings for Clover Health Investments Corp. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $2.05, which is $0.77 above the current price. CLOV currently public float of 346.34M and currently shorts hold a 8.80% ratio of that float. Today, the average trading volume of CLOV was 6.90M shares.
CLOV’s Market Performance
CLOV stocks went up by 3.23% for the week, with a monthly jump of 32.07% and a quarterly performance of -10.49%, while its annual performance rate touched -54.29%. The volatility ratio for the week stands at 6.71% while the volatility levels for the past 30 days are set at 8.00% for Clover Health Investments Corp. The simple moving average for the period of the last 20 days is 20.98% for CLOV stocks with a simple moving average of -39.63% for the last 200 days.
Analysts’ Opinion of CLOV
Many brokerage firms have already submitted their reports for CLOV stocks, with Cowen repeating the rating for CLOV by listing it as a “Market Perform.” The predicted price for CLOV in the upcoming period, according to Cowen is $3 based on the research report published on February 02nd of the previous year 2022.
Canaccord Genuity, on the other hand, stated in their research note that they expect to see CLOV reach a price target of $6. The rating they have provided for CLOV stocks is “Buy” according to the report published on February 02nd, 2022.
SVB Leerink gave a rating of “Mkt Perform” to CLOV, setting the target price at $3 in the report published on January 19th of the previous year.
CLOV Trading at 9.74% from the 50-Day Moving Average
After a stumble in the market that brought CLOV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.18% of loss for the given period.
Volatility was left at 8.00%, however, over the last 30 days, the volatility rate increased by 6.71%, as shares surge +31.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.78% lower at present.
During the last 5 trading sessions, CLOV rose by +3.23%, which changed the moving average for the period of 200-days by -63.01% in comparison to the 20-day moving average, which settled at $1.0733. In addition, Clover Health Investments Corp. saw 37.71% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at CLOV starting from SHAPIRO LEE, who purchase 80,000 shares at the price of $3.10 back on Mar 11. After this action, SHAPIRO LEE now owns 107,100 shares of Clover Health Investments Corp., valued at $248,072 using the latest closing price.
Clinton Chelsea, the Director of Clover Health Investments Corp., purchase 100,000 shares at $2.53 during a trade that took place back on Mar 03, which means that Clinton Chelsea is holding 100,000 shares at $252,530 based on the most recent closing price.
Stock Fundamentals for CLOV
Current profitability levels for the company are sitting at:
- -37.11 for the present operating margin
The net margin for Clover Health Investments Corp. stands at -38.21. Equity return is now at value -95.90, with -24.40 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.02.